identifying patients with lung cancer who benefit from immunotherapy
Published 6 years ago • 127 plays • Length 2:26Download video MP4
Download video MP3
Similar videos
-
1:35
enrolling patients with lung cancer into clinical trials for immunotherapy
-
17:30
immunotherapy in lung cancer: panacea vs. reality?
-
1:04
addressing the role of consolidation immunotherapy in patients with lung cancer
-
1:15
exploring biomarkers for immunotherapy treatment in lung cancer
-
57:44
lung cancer? what patients need to know about immunotherapy, with leena gandhi
-
3:42
how do lung cancer patients benefit from mrd testing?
-
1:48
assessing immunotherapy in various subtypes of lung cancer
-
1:49
addressing unmet needs in patients with lung cancer
-
0:45
how to discuss immunotherapy as a treatment option with lung cancer patients
-
2:43
clinical factors in the selection of patients for first-line immunotherapy of lung cancer
-
59:19
precision oncology in early-stage lung cancer, with adjuvant egfr-targeted therapy leading the way
-
2:46
unanswered questions in treating lung cancer with immunotherapy
-
59:37
marking new milestones with immunotherapy in locally advanced and early lung cancer
-
0:56
dr. papadimitrakopoulou on role of immunotherapy in lung cancer
-
19:05
what we know about immunotherapy treatments for lung cancer
-
4:15
the toxicities associated with immunotherapy in lung cancer patients
-
55:16
targeting tigit to extend immunotherapy benefits to more cancer patients
-
2:38
lung cancer: from immunotherapy to precision medicine
-
1:18:32
advanced gi cancers: identifying and targeting uncommon but actionable genomic alterations